← Back to Search

Procedure

Nerve Transfer Surgery for Stroke Recovery

N/A

Waitlist Available

Led By Jennifer Hong, Dr.

Research Sponsored by Dartmouth-Hitchcock Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

History of ischemic or hemorrhagic stroke with resultant arm paresis that has ceased to improve within 1-5 years of rehabilitation.

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 months with visits at baseline and months 2, 4, 8, and 12 months after surgery.

Awards & highlights

Study Summary

This trial looks at how well surgery to transfer a nerve can improve arm/leg function after a stroke.

Who is the study for?

This trial is for stroke survivors with arm weakness or paralysis who haven't seen improvement after 1-5 years of rehab. It's not suitable for pregnant individuals.Check my eligibility

What is being tested?

The study tests a surgical procedure called contralateral C7 root transfer, aiming to improve arm function in patients with spastic hemiparesis due to stroke.See study design

What are the potential side effects?

Potential side effects may include discomfort at the surgery site, infection risk, nerve damage, and possibly limited movement improvements.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I had a stroke that left my arm weak, and it hasn't gotten better in 1-5 years despite therapy.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 months with visits at baseline and months 2, 4, 8, and 12 months after surgery.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 months with visits at baseline and months 2, 4, 8, and 12 months after surgery.

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months with visits at baseline and months 2, 4, 8, and 12 months after surgery. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change from baseline in arm function, as measured by the Fugl-Meyer upper-extremity scale.

Trial Design

1Treatment groups

Experimental Treatment

Group I: Contralateral C7 root transfer for the treatment of spastic hemiparesis.Experimental Treatment1 Intervention

The C7 nerve root transfer will occur to the patients on this arm.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Dartmouth-Hitchcock Medical CenterLead Sponsor

524 Previous Clinical Trials

2,543,246 Total Patients Enrolled

Jennifer Hong, Dr.Principal InvestigatorDartmouth-Hitchcock Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research study include participants aged 30 and above?

"The age range for those eligible to participate in this study ranges from 18 years old up to 65."

Answered by AI

Is recruitment for this experiment still underway?

"Based on the information available at clinicaltrials.gov, this particular trial is not actively enrolling participants despite initially being posted in March of 2022 and last edited in August 2023. However, there are 1234 other medical studies that are recruiting patients as we speak."

Answered by AI

Who meets the criteria to participate in this experiment?

"To qualify for this research, individuals must be afflicted with a hemorrhagic stroke and have an age between 18-65 years. This clinical trial is in search of 95 participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Utility of CC7 Transfer in Stroke Subtypes

Jennifer Hong 2022. "Utility of CC7 Transfer in Stroke Subtypes". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06001736.